Ultragenyx Pharmaceutical | RARE - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Acadia Pharmaceuticals USD 3.8B 724M 2026-03
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
BioMarin Pharmaceutical USD 10.86B 553M 2026-03
Esperion Therapeutics USD 885M 351M 2025-12
Immunic USD 64M 23M 2025-12
Insmed USD 35.3B 1.82B 2026-03
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
Karyopharm Therapeutics USD 1.05B 912M 2026-06
Kyowa Hakko Kirin JPY 1.36T 26.81B 2026-03
Moderna USD 20.15B 8.53B 2026-03
Neurocrine Biosciences USD 13.25B 890M 2026-03
PTC Therapeutics USD 5.64B 460M 2026-03
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Sarepta Therapeutics USD 2.28B 30M 2026-03
Ultragenyx Pharmaceutical USD 2.06B 159M 2026-03
Vertex Pharmaceuticals USD 113.58B 1.44B 2026-03